StockNews.AI
GERN
StockNews.AI
173 days

Kirby McInerney LLP Announces Investigation Against Geron Corporation (GERN) on Behalf of Investors

1. Kirby McInerney LLP is investigating Geron for potential securities law violations. 2. Geron reported flat revenue trends for Rytelo, impacting share prices significantly. 3. Shares dropped 32%, falling from $2.37 to $1.61 after earnings announcement. 4. The investigation could lead to legal ramifications for Geron and its executives.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The substantial drop in share price and investigation signals major investor concern. Historical cases of similar investigations have often resulted in prolonged stock declines.

How important is it?

The investigation's potential impact on Geron's financial standing is significant. Investor trust could deteriorate further, affecting stock price and market perception.

Why Short Term?

Immediate investor reaction to the investigation is likely to persist in the short term. Past examples show significant volatility in stocks under investigation, affecting investor sentiment rapidly.

Related Companies

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Geron Corporation (“Geron” or the “Company”) (NASDAQ:GERN). The investigation concerns whether Geron and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] On February 26, 2025, Geron announced its financial results for the fourth year and full year 2024. During a related earnings call, Geron’s executives said that the Company has “observed flat revenue trends over the last few months” for its recently approved blood disorder drug, Rytelo. On this news, the price of Geron shares declined by $0.76 per share, or approximately 32%, from $2.37 per share on February 25, 2025, to close at $1.61 on February 26, 2025. If you purchased or otherwise acquired Geron securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out the form below to discuss your rights or interests with respect to these matters without any cost to you. [CONTACT US] Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. ContactsKirby McInerney LLPThomas W. Elrod, Esq.212-699-1180https://www.kmllp.cominvestigations@kmllp.com

Related News